Beverley Sayles
Acute Care · Toms River, NJNPI 1376178871
Payments from drug & device makers
Across 100 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$355
- AbbVie$304
- Regeneron Healthcare Solutions, Inc.$217
- Taiho Oncology, Inc.$157
- Merck$83
- Mannkind Corporation$80
- plus $640 from 22 others
What the payments were for
- Food & beverage$1,81899%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 11 | $355 |
| AbbVie | 23 | $304 |
| Regeneron Healthcare Solutions, Inc. | 6 | $217 |
| Taiho Oncology, Inc. | 8 | $157 |
| Merck | 5 | $83 |
| Mannkind Corporation | 6 | $80 |
| Lilly USA, LLC | 5 | $75 |
| Bayer | 3 | $57 |
| Sanofi-aventis U.S. LLC | 4 | $55 |
| Johnson & Johnson(2 entities) | 2 | $51 |
| AstraZeneca | 3 | $49 |
| Pfizer | 3 | $44 |
| Genentech USA, Inc. | 2 | $32 |
| Daiichi Sankyo Inc. | 2 | $30 |
| Biohaven Pharmaceuticals, Inc. | 2 | $28 |
| Boehringer Ingelheim | 2 | $28 |
| Gilead | 2 | $26 |
| Bristol Myers Squibb | 1 | $18 |
| Pharmacosmos Therapeutics Inc. | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Coherus Oncology, Inc. | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
| Novo Nordisk | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$238
- LIBTAYO$100
How this compares
$1,836 in reported general payments places this provider in the 85th percentile of 656 acute care providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 44 | $20,593 |
| Midodrine Hcl | 30 | $2,368 |
| Sucralfate | 11 | $1,213 |
| Atorvastatin Calcium | 54 | $755 |
| Pantoprazole Sodium | 78 | $572 |
| Metoprolol Succinate | 39 | $518 |
| Bumetanide | 11 | $316 |
| Donepezil Hcl | 14 | $311 |
| Gabapentin | 27 | $290 |
| Mirtazapine | 11 | $288 |
| Sertraline Hcl | 23 | $271 |
| Nifedipine ErNifedipine | 13 | $270 |
| CefuroximeCefuroxime Axetil | 13 | $234 |
| Doxycycline Hyclate | 16 | $220 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 11 | $210 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $44 | $20,59344 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 656 acute care providers in New Jersey.
Other acute care in Toms River
- Gabriella MagarelliHackensack$44K
- Per RosenkvistLivingston$29K
- Matthew OstroffPaterson$27K
- Ellen McCueNeptune$26K
- Suzanne ShuggLivingston$25K
- Maria Tedi CoronelHackensack$19K
- Hanane ChaibainouWestampton$16K
- Jennifer McCarthyNewark$16K
- Jennifer HarrarCamden$16K
- Vincent FroncekFlemington$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.